Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome

By Karabulut Aysun   Turgut Sebahat   Turgut Günfer  

Gynecological Endocrinology, Vol. 26, Iss. 6, 2010-06 ,pp. : 393-398

Informa Healthcare

Access to resources Recommend Favorite

Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome

By Yilmaz Murat   Bi˙ri˙ Aydan   Bukan Neslihan   Karakoç Ayhan   Sancak Banu   Törüner Füsun   Paşaoğlu Hatice  

Gynecological Endocrinology, Vol. 20, Iss. 5, 2005-05 ,pp. : 258-263

Informa Healthcare

Access to resources Recommend Favorite

Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome

By Chen Mei-Jou   Yang Wei-Shiung   Chen Hsin-Fu   Kuo Jahn-Jahn   Ho Hong-Nerng   Yang Yu-Shih   Chen Shee-Uan  

Human Reproduction, Vol. 25, Iss. 3, 2010-03 ,pp. : 779-785

Oxford University Press

Access to resources Recommend Favorite

The role of plasma renin activity in distinguishing patients with polycystic ovary syndrome (PCOS) from oligomenorrheic patients without PCOS

By Uncu G.   Sözer M. C.   Develioğlu O.   Cengiz C.  

Gynecological Endocrinology, Vol. 16, Iss. 6, 2002-12 ,pp. : 447-452

Informa Healthcare

Access to resources Recommend Favorite

Is Combined Angiotensin-converting Enzyme Inhibition and Angiotensin Receptor Blockade Associated with Increased Risk of Cardiovascular Death in Hemodialysis Patients?

By  

Current Hypertension Reviews, Vol. 8, Iss. 4, 2012-11 ,pp. : 256-266

Bentham Science Publishers

Access to resources Recommend Favorite